InfuSystem Holdings, Inc. (INFU)
Stock Price:
$16.74 USD
0.18 (1.09%)
Updated December 3, 12:15 PM EST - Market open
Key Info
| Market Cap |
338.77M |
| Revenue (ttm) |
94.39M |
| Net Income (ttm) |
7.47M |
| Shares Out |
20.18M |
| EPS (ttm) |
0.35 |
| PE Ratio |
47.83 |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
December 3 |
| Last Price |
$16.74 |
| Previous Close |
$16.56 |
| Change ($) |
0.18 |
| Change (%) |
1.09% |
| Day's Open |
16.66 |
| Day's Range |
16.56 - 16.74 |
| Day's Volume |
19,650 |
| 52-Week Range |
5.70 - 16.74 |
More Stats
| Market Cap |
338.77M |
| Enterprise Value |
375.68M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
20.18M |
| Float |
n/a |
| EPS (basic) |
0.38 |
| EPS (diluted) |
0.35 |
| FCF / Share |
0.13 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
2.09% |
| FCF Yield |
0.77% |
| Payout Ratio |
n/a |
| Shares Short |
189,984 |
| Short Ratio |
2.26 |
| Short % of Float |
n/a |
| Beta |
0.73 |
| PE Ratio |
47.83 |
| Forward PE |
n/a |
| P/FCF Ratio |
130.45 |
| PS Ratio |
3.59 |
| PB Ratio |
10.94 |
| Revenue |
94.39M |
| Operating Income |
9.05M |
| Net Income |
7.47M |
| Free Cash Flow |
2.60M |
| Net Cash |
-36.92M |
| Net Cash / Share |
-1.82 |
| Gross Margin |
49.97% |
| Operating Margin |
9.59% |
| Profit Margin |
7.90% |
| FCF Margin |
2.75% |
| ROA |
7.62% |
| ROE |
29.22% |
| ROIC |
10.30% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Ratings (2)
| Buy |
2 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$24.50*
(46.36% upside)
Low
21.0
Current: $16.74
High
28.0
Target: 24.50
*Average 12-month price target from 2 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 81.12 | 67.14 | 71.08 | 70.50 | 70.54 | 66.49 | 62.28 | 58.83 | 54.64 | 47.23 |
| Revenue Growth | 20.82% | -5.54% | 0.82% | -0.06% | 6.1% | 6.75% | 5.87% | 7.67% | 15.69% | - |
| Gross Profit | 46.88 | 39.57 | 43.36 | 44.74 | 49.60 | 47.35 | 43.68 | 42.91 | 35.36 | 33.55 |
| Operating Income | 3.43 | 0.38 | -3.81 | 0.97 | 7.28 | 9.33 | 5.90 | 2.00 | -66.36 | -0.94 |
| Net Income | 1.36 | -1.10 | -20.71 | -0.22 | 2.79 | 3.36 | 1.67 | -1.49 | -45.44 | -1.85 |
| Shares Outstanding | 19.73 | 21.42 | 22.74 | 22.62 | 22.41 | 22.15 | 21.87 | 21.43 | 21.07 | 19.72 |
| Earnings Per Share | 0.07 | -0.05 | -0.91 | -0.01 | 0.12 | 0.15 | 0.08 | -0.07 | -2.16 | -0.09 |
| EPS Growth | - | - | - | - | -20% | 87.5% | - | - | - | - |
| Operating Cash Flow | 13.88 | 11.39 | 7.72 | 7.91 | 7.05 | 7.26 | 7.46 | 5.45 | 6.75 | 10.81 |
| Capital Expenditures | -19.64 | -4.98 | 1.11 | -1.45 | -0.02 | 0.71 | -0.92 | -2.56 | -3.99 | -2.44 |
| Free Cash Flow | -5.77 | 6.41 | 8.83 | 6.46 | 7.04 | 7.96 | 6.54 | 2.89 | 2.75 | 8.37 |
| Cash & Equivalents | 2.65 | 4.32 | 3.47 | 3.40 | 0.82 | 0.52 | 1.14 | 2.33 | 0.80 | 5.01 |
| Total Debt | 43.02 | 33.75 | 28.93 | 37.40 | 34.81 | 25.48 | 26.73 | 31.27 | 29.13 | 32.20 |
| Net Cash / Debt | -40.37 | -29.43 | -25.46 | -34.00 | -33.99 | -24.97 | -25.59 | -28.94 | -28.33 | -27.18 |
| Assets | 79.22 | 64.07 | 68.88 | 96.34 | 95.36 | 80.21 | 77.37 | 77.52 | 76.26 | 130 |
| Liabilities | 56.89 | 43.63 | 37.93 | 45.66 | 45.04 | 33.76 | 34.65 | 37.51 | 36.10 | 45.22 |
| Book Value | 22.33 | 20.44 | 30.95 | 50.69 | 50.32 | 46.45 | 42.72 | 40.01 | 40.17 | 85.14 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
InfuSystem Holdings, Inc. |
| Employees |
261 |
Stock Information
| Ticker Symbol |
INFU |
| Stock Exchange |
NYSE American |
| Sector |
Healthcare |
| Industry |
Medical Instruments & Supplies |
| Unique Identifier |
NYSEAMERICAN: INFU |
Description
InfuSystem Holdings, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was founded in 2005 and is headquartered in Madison Heights, Michigan.